French `ban' fails to deter AIDS pioneer

Brown, Phyllida; Concar, David
June 1991
New Scientist;6/22/91, Vol. 130 Issue 1774, p18
Reveals that French AIDS researcher Daniel Zagury announced that he had tested a new form of immune therapy on people with HIV just a few days after the French health minister banned him from carrying out further clinical trials of a previous immune therapy. Death of three patients in the previous study; Zagury's belief in the new trials; Mixed reactions from the scientific community; Robert Gallo of the National Cancer Institute in the US.


Related Articles

  • 'Unethical' tests split HIV researchers. Brown, Phyllida // New Scientist;3/16/91, Vol. 129 Issue 1760, p14 

    Reports that government laboratories in the United States have been forbidden to work with Daniel Zagury, a French researcher, due to allegations that certain projects have failed to meet ethical guidelines of the National Institutes of Health (NIH); Testing of a potential AIDS vaccine in France...

  • HIV/AIDS clinical trials critical for minority women, according to study. Townes, Glenn // New York Amsterdam News;8/20/2009, Vol. 100 Issue 34, p26 

    The article presents information on the study GRACE (Gender, Race and Clinical Experience) which analyzes race and gender differences. It notes that the study conducted a clinical trial to 287 women and 142 men with HIV by a therapy regimen which includes the drug Prezista (darunavir) and Norvir...

  • AIDS Campaign Spotlights Global Clinical Research. Wechsler, Jill // Applied Clinical Trials;Feb2003, Vol. 12 Issue 2, p22 

    Focuses on the various international clinical research trials on the development of therapies for AIDS, malaria and tuberculosis in developing nations. Total number of AIDS medicine tested by medical researchers; Details on the growing support for global disease research; Inability of...

  • Expanding AIDS Drug Availability. Marwick, Charles // JAMA: Journal of the American Medical Association;9/8/89, Vol. 262 Issue 10, p1289 

    Cites the U.S. Food and Drug Administration's endorsement in principle of the concept of expanding the availability of drugs at the early stages of AIDS for treatment. Support for the initiative from AIDS activist groups and National Institute of Allergy and Infectious Diseases members; Issues...

  • Transnational medicine in public arenas: AIDS treatments in the South. Dodier, Nicolas // Culture, Medicine & Psychiatry;Sep2005, Vol. 29 Issue 3, p285 

    This article looks at the AIDS-related controversy surrounding the experiments on and the availability of medicines in southern countries. It situates these debates in a longer-term history of transnational medicine. It highlights the rise of international therapeutic modernity at the beginning...

  • French AIDS researcher cleared over vaccine trials. Hughes, Sylvia // New Scientist;4/13/91, Vol. 130 Issue 1764, p10 

    Announces that an inquiry has found that trials conducted in France by AIDS researcher Daniel Zagury did not breach ethical guidelines. Tests of an experimental AIDS vaccine and immune therapy at a Paris hospital; Other controversy involving Zagury and tests on adults and children in Zaire;...

  • Trial and failure.  // Nature;3/1/2007, Vol. 446 Issue 7131, p1 

    The author expresses his view on the failure of the clinical trial of cellulose sulphate vaginal gel against human immunodeficiency virus (HIV) infection. The author shared that microbicide researchers were disappointed with the outcome and a blow to African women. The author suggested that all...

  • European initiative to provide Africa with control of therapeutic development. Clarke, Tom // Nature Reviews Drug Discovery;Nov2003, Vol. 2 Issue 11, p853 

    Reports that the European Commission is inviting applications for a new funding scheme, called the Europe-Development Countries Clinical Trials Partnership (EDCTP), designed to put Africans in control of developing treatments for HIV/AIDS, tuberculosis and malaria in the continent. Skepticism...

  • Randomised controlled trials in Africa of HIV and AIDS descriptive study and spatial distribution. Siegfried, Nandi; Clarke, Mike; Volmink, Jimmy // BMJ: British Medical Journal (International Edition);10/1/2005, Vol. 331 Issue 7519, p742 

    Objectives To identify and describe randomized controlled trials on HIV and AIDS conducted in Africa and to map their spatial distribution using exact geographic coordinates. Design Construction and analysis of a database of trials conducted wholly or partly in Africa and reported before 2004....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics